RIZATRIPTAN BENZOATE

RIZATRIPTAN BENZOATE was reported 10325 times

RIZATRIPTAN BENZOATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NEOVASCULARISATION 61 0.2319
1 LIGAMENTUM FLAVUM HYPERTROPHY 7 0.1522
2 CERVICOGENIC HEADACHE 15 0.1103
3 PINEAL GLAND CYST 14 0.1000
4 PURPURA SENILE 12 0.0984
5 OSTEOARTHROPATHY 7 0.0959
6 POST-TRAUMATIC HEADACHE 14 0.0892
7 MIGRAINE WITHOUT AURA 23 0.0767
8 POSTNATAL GROWTH RESTRICTION 9 0.0687
9 TARSAL TUNNEL SYNDROME 11 0.0500
10 CARCINOMA IN SITU 7 0.0419
11 VASCULAR GRAFT OCCLUSION 16 0.0417
12 PRODUCT USED FOR UNKNOWN INDICATION 50 0.0397
13 GASTROENTERITIS RADIATION 10 0.0305
14 GALLBLADDER POLYP 23 0.0293
15 DUST ALLERGY 21 0.0214
16 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 52 0.0195
17 SEDATION 503 0.0192
18 MEDICATION OVERUSE HEADACHE 15 0.0175
19 PARADOXICAL DRUG REACTION 64 0.0174
20 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 17 0.0160
21 REFLUX OESOPHAGITIS 11 0.0145
22 NASAL DISCHARGE DISCOLOURATION 20 0.0145
23 NIGHTMARE 501 0.0145
24 BILIARY DYSKINESIA 24 0.0141
25 ALLERGY TO ANIMAL 15 0.0141
26 RESORPTION BONE INCREASED 11 0.0134
27 COMPLEX REGIONAL PAIN SYNDROME 19 0.0129
28 OCCIPITAL NEURALGIA 7 0.0124
29 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 16 0.0118
30 PRE-EXISTING CONDITION IMPROVED 72 0.0115
31 SUSPICIOUSNESS 8 0.0114
32 MIGRAINE 999 0.0105
33 INFUSION SITE URTICARIA 7 0.0104
34 NEPHROLITHIASIS 470 0.0102
35 OESOPHAGITIS ULCERATIVE 7 0.0102
36 TOE OPERATION 8 0.0102
37 CHOLECYSTITIS CHRONIC 68 0.0101
38 VESTIBULAR DISORDER 12 0.0098
39 SUPERIOR SAGITTAL SINUS THROMBOSIS 7 0.0088
40 BURNS THIRD DEGREE 9 0.0085
41 INTRACRANIAL VENOUS SINUS THROMBOSIS 9 0.0084
42 SWOLLEN TONGUE 259 0.0083
43 DACTYLITIS 8 0.0081
44 NEUROPSYCHIATRIC SYMPTOMS 7 0.0078
45 MIGRAINE WITH AURA 20 0.0074
46 ANURIA 63 0.0073
47 GALLBLADDER INJURY 14 0.0072
48 ORAL MUCOSAL ERYTHEMA 11 0.0071
49 ABORTION MISSED 9 0.0071
50 CATAPLEXY 10 0.0071
51 ORAL PRURITUS 16 0.0070
52 THROMBOPHLEBITIS SUPERFICIAL 21 0.0069
53 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 13 0.0066
54 BRONCHIAL OBSTRUCTION 9 0.0064
55 VERTIGO POSITIONAL 11 0.0063
56 RENAL INFARCT 9 0.0062
57 LUMBAR RADICULOPATHY 7 0.0060
58 NARCOLEPSY 11 0.0058
59 PRETERM PREMATURE RUPTURE OF MEMBRANES 7 0.0058
60 PRODUCT ADMINISTRATION INTERRUPTED 45 0.0057
61 BLADDER PROLAPSE 7 0.0057
62 MOTION SICKNESS 11 0.0057
63 ANGIOEDEMA 242 0.0055
64 LIMB MASS 12 0.0055
65 CALCIUM DEFICIENCY 7 0.0054
66 TENSION HEADACHE 23 0.0053
67 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS 10 0.0053
68 SINUS PAIN 12 0.0051
69 ARTERIOSPASM CORONARY 20 0.0050
70 NASAL OEDEMA 9 0.0050
71 PRODUCT SOLUBILITY ABNORMAL 25 0.0049
72 AURA 9 0.0048
73 MITRAL VALVE PROLAPSE 8 0.0048
74 HYPERHIDROSIS 606 0.0047
75 DYSPHONIA 273 0.0047
76 EPICONDYLITIS 7 0.0046
77 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 248 0.0045
78 TEMPOROMANDIBULAR JOINT SYNDROME 12 0.0045
79 KOUNIS SYNDROME 10 0.0044
80 ESSENTIAL HYPERTENSION 8 0.0044
81 TORTICOLLIS 9 0.0042
82 SWELLING FACE 272 0.0042
83 GASTRIC BYPASS 9 0.0041
84 HYPOGEUSIA 8 0.0041
85 ACUTE SINUSITIS 7 0.0041
86 HANGOVER 14 0.0040
87 ABDOMINAL ADHESIONS 12 0.0038
88 BILIARY COLIC 11 0.0038
89 SLEEP APNOEA SYNDROME 70 0.0037
90 CLUMSINESS 10 0.0037
91 CRANIOCEREBRAL INJURY 11 0.0036
92 VISUAL FIELD DEFECT 26 0.0036
93 VITAMIN D DEFICIENCY 35 0.0036
94 NASAL SEPTUM DEVIATION 7 0.0036
95 HYPERACUSIS 13 0.0035
96 DRUG INTOLERANCE 335 0.0035
97 SNORING 13 0.0034
98 AUTONOMIC NERVOUS SYSTEM IMBALANCE 10 0.0034
99 EAR PRURITUS 12 0.0034
100 PULMONARY INFARCTION 8 0.0034
101 RHINITIS ALLERGIC 15 0.0034
102 HYPOSPADIAS 7 0.0034
103 FACIAL PAIN 30 0.0034
104 ENDOMETRIOSIS 16 0.0034
105 SOMNAMBULISM 22 0.0033
106 HYDROCEPHALUS 18 0.0033
107 RASH MORBILLIFORM 9 0.0032
108 INFUSION SITE BRUISING 7 0.0032
109 FEELING OF DESPAIR 15 0.0032
110 CHRONIC SINUSITIS 12 0.0032
111 INFUSION SITE PRURITUS 10 0.0032
112 FIBROMYALGIA 77 0.0032
113 POST-TRAUMATIC STRESS DISORDER 21 0.0031
114 BLOOD CHLORIDE DECREASED 8 0.0031
115 SENSATION OF HEAVINESS 12 0.0031
116 HEAD DISCOMFORT 54 0.0030
117 GALLBLADDER DISORDER 54 0.0030
118 THERAPY PARTIAL RESPONDER 47 0.0030
119 PREMATURE LABOUR 17 0.0030
120 BRONCHITIS CHRONIC 7 0.0029
121 RESPIRATORY RATE DECREASED 9 0.0029
122 CHOLELITHIASIS 93 0.0028
123 FIBULA FRACTURE 8 0.0028
124 HYPERTONIC BLADDER 8 0.0028
125 NECK INJURY 8 0.0027
126 MUSCLE TIGHTNESS 44 0.0027
127 EXTRAPYRAMIDAL DISORDER 67 0.0027
128 RADICULOPATHY 7 0.0027
129 PERONEAL NERVE PALSY 15 0.0026
130 ABDOMINAL TENDERNESS 13 0.0026
131 SEROTONIN SYNDROME 50 0.0026
132 PRODUCT USE IN UNAPPROVED INDICATION 643 0.0026
133 PANIC DISORDER 10 0.0026
134 RHINALGIA 7 0.0025
135 EAR DISCOMFORT 26 0.0025
136 SINUS HEADACHE 15 0.0025
137 SINUSITIS 257 0.0025
138 POLYARTHRITIS 13 0.0025
139 MAJOR DEPRESSION 18 0.0025
140 CONCUSSION 19 0.0025
141 SCOLIOSIS 15 0.0024
142 ANXIETY DISORDER 8 0.0024
143 DRUG TOLERANCE 12 0.0024
144 FACE INJURY 9 0.0024
145 FRUSTRATION TOLERANCE DECREASED 19 0.0023
146 CLAVICLE FRACTURE 9 0.0023
147 TIBIA FRACTURE 11 0.0023
148 GINGIVAL DISORDER 9 0.0023
149 CENTRAL VENOUS CATHETERISATION 7 0.0023
150 REBOUND ACID HYPERSECRETION 7 0.0023
151 CHOLECYSTITIS ACUTE 13 0.0023
152 FEELING DRUNK 17 0.0023
153 SKIN ODOUR ABNORMAL 9 0.0023
154 MENISCUS INJURY 14 0.0023
155 EAR PAIN 44 0.0023
156 APPENDICECTOMY 8 0.0022
157 TEMPERATURE INTOLERANCE 23 0.0022
158 BRUXISM 12 0.0022
159 INFUSION SITE SWELLING 14 0.0022
160 COLITIS ISCHAEMIC 15 0.0022
161 OESOPHAGITIS 24 0.0022
162 INTERVERTEBRAL DISC PROTRUSION 48 0.0022
163 BRAIN INJURY 22 0.0022
164 HYPERSENSITIVITY 407 0.0022
165 SPINAL STENOSIS 9 0.0022
166 PHOTOPHOBIA 41 0.0022
167 EYELID PTOSIS 22 0.0022
168 SPINAL OSTEOARTHRITIS 19 0.0022
169 INTRACRANIAL PRESSURE INCREASED 12 0.0022
170 TENDON INJURY 8 0.0021
171 PRODUCT TASTE ABNORMAL 29 0.0021
172 SKIN INFECTION 24 0.0021
173 THROAT CLEARING 8 0.0021
174 INFUSION SITE HAEMORRHAGE 7 0.0021
175 BLOOD DISORDER 17 0.0021
176 THERMAL BURN 15 0.0021
177 INTERVERTEBRAL DISC DISORDER 9 0.0021
178 THERAPEUTIC PRODUCT EFFECT VARIABLE 8 0.0021
179 IMPAIRED GASTRIC EMPTYING 28 0.0021
180 DYSPHEMIA 9 0.0021
181 SEASONAL ALLERGY 29 0.0020
182 INFUSION SITE ERYTHEMA 17 0.0020
183 HYPERREFLEXIA 7 0.0020
184 WOUND INFECTION 22 0.0020
185 SINUS CONGESTION 27 0.0020
186 MUSCLE CONTRACTIONS INVOLUNTARY 7 0.0020
187 TRIGEMINAL NEURALGIA 8 0.0020
188 APHASIA 60 0.0020
189 FUNGAL SKIN INFECTION 8 0.0020
190 BRONCHITIS 145 0.0020
191 PHLEBITIS 10 0.0020
192 ORAL DISCOMFORT 27 0.0019
193 NEPHROGENIC ANAEMIA 9 0.0019
194 TRISMUS 10 0.0019
195 PRODUCT PHYSICAL ISSUE 39 0.0019
196 NEURALGIA 47 0.0019
197 BIPOLAR DISORDER 21 0.0019
198 CHOLECYSTECTOMY 22 0.0019
199 THERAPEUTIC RESPONSE UNEXPECTED 86 0.0019
200 WEIGHT FLUCTUATION 20 0.0019
201 FOOD INTOLERANCE 7 0.0019
202 SELF-INJURIOUS IDEATION 8 0.0019
203 SPUTUM DISCOLOURED 18 0.0019
204 INCORRECT DRUG ADMINISTRATION RATE 8 0.0019
205 CARDIAC FLUTTER 12 0.0019
206 PAROSMIA 14 0.0019
207 AUTOIMMUNE THYROIDITIS 7 0.0018
208 HORMONE LEVEL ABNORMAL 9 0.0018
209 BRADYPHRENIA 12 0.0018
210 THYROID MASS 7 0.0018
211 GASTRITIS 48 0.0018
212 ONYCHOMYCOSIS 8 0.0018
213 TENDERNESS 19 0.0018
214 IRRITABLE BOWEL SYNDROME 39 0.0018
215 RESTLESS LEGS SYNDROME 33 0.0018
216 THROAT TIGHTNESS 49 0.0018
217 DENTAL CARIES 20 0.0018
218 OVARIAN CYST 18 0.0018
219 DEEP VEIN THROMBOSIS 117 0.0018
220 INCONTINENCE 19 0.0018
221 INJURY 126 0.0018
222 NECK PAIN 100 0.0018
223 MENINGITIS ASEPTIC 8 0.0018
224 DIPLOPIA 46 0.0018
225 VITAMIN D DECREASED 15 0.0018
226 CROHN'S DISEASE 12 0.0017
227 EAR DISORDER 8 0.0017
228 FOOT FRACTURE 33 0.0017
229 RHINITIS 14 0.0017
230 RETCHING 37 0.0017
231 LYMPHOEDEMA 12 0.0017
232 ENURESIS 7 0.0017
233 HYSTERECTOMY 15 0.0017
234 SCREAMING 11 0.0017
235 APPLICATION SITE DISCOLOURATION 7 0.0017
236 HEADACHE 1080 0.0017
237 ROSACEA 8 0.0017
238 PERIPHERAL VENOUS DISEASE 7 0.0017
239 DUODENAL ULCER 12 0.0017
240 LYMPHOPENIA 24 0.0017
241 SCAR 29 0.0017
242 SKIN ABRASION 8 0.0017
243 ATTENTION DEFICIT HYPERACTIVITY DISORDER 7 0.0017
244 EUPHORIC MOOD 17 0.0017
245 EXOSTOSIS 15 0.0016
246 SHOULDER OPERATION 7 0.0016
247 FEELING JITTERY 31 0.0016
248 IRON DEFICIENCY ANAEMIA 15 0.0016
249 INTERVERTEBRAL DISC DEGENERATION 15 0.0016
250 PANIC ATTACK 59 0.0016
251 FOOT OPERATION 8 0.0016
252 MULTIPLE SCLEROSIS RELAPSE 110 0.0016
253 NAUSEA 1267 0.0016
254 HYPERLIPIDAEMIA 19 0.0016
255 BLEPHAROSPASM 10 0.0016
256 AUTOIMMUNE HEPATITIS 11 0.0016
257 SINUS DISORDER 31 0.0016
258 BACK INJURY 17 0.0016
259 MUSCLE TWITCHING 36 0.0016
260 ROTATOR CUFF SYNDROME 20 0.0016
261 LIVE BIRTH 13 0.0016
262 SUICIDAL IDEATION 142 0.0015
263 APHTHOUS ULCER 12 0.0015
264 PARAESTHESIA 243 0.0015
265 DRUG EFFECT DELAYED 7 0.0015
266 PELVIC PAIN 28 0.0015
267 EAR INFECTION 41 0.0015
268 PARALYSIS 22 0.0015
269 THERAPEUTIC PRODUCT EFFECT DELAYED 7 0.0015
270 PHARYNGEAL SWELLING 15 0.0015
271 CENTRAL NERVOUS SYSTEM LESION 21 0.0015
272 LYMPHOCYTE COUNT DECREASED 27 0.0015
273 PANIC REACTION 11 0.0015
274 TINNITUS 70 0.0015
275 LIGAMENT SPRAIN 15 0.0015
276 DEPRESSION 345 0.0015
277 SYNOVIAL CYST 7 0.0015
278 OSTEOARTHRITIS 64 0.0015
279 OSTEOPOROSIS 62 0.0015
280 ROAD TRAFFIC ACCIDENT 63 0.0015
281 SENSORY LOSS 12 0.0015
282 STRESS FRACTURE 8 0.0015
283 PHARYNGITIS STREPTOCOCCAL 16 0.0015
284 TOOTH ABSCESS 15 0.0015
285 FEELING HOT 90 0.0015
286 NONSPECIFIC REACTION 8 0.0015
287 PHOTOSENSITIVITY REACTION 24 0.0015
288 PULMONARY EMBOLISM 138 0.0015
289 DEAFNESS UNILATERAL 8 0.0015
290 HEPATIC STEATOSIS 27 0.0014
291 PRODUCT AVAILABILITY ISSUE 33 0.0014
292 ATELECTASIS 14 0.0014
293 HYPOKINESIA 21 0.0014
294 DYSPEPSIA 142 0.0014
295 LIMB INJURY 39 0.0014
296 ATAXIA 17 0.0014
297 ANGIOPATHY 8 0.0014
298 CHEST DISCOMFORT 146 0.0014
299 APPLICATION SITE BURN 7 0.0014
300 UTERINE PERFORATION 12 0.0014
301 THERAPEUTIC RESPONSE SHORTENED 47 0.0014
302 RENAL PAIN 15 0.0014
303 PERIORBITAL SWELLING 8 0.0014
304 ANXIETY 402 0.0014
305 VERTIGO 86 0.0014
306 BLADDER DISORDER 14 0.0014
307 DISTURBANCE IN ATTENTION 76 0.0014
308 ANHEDONIA 37 0.0014
309 DYSARTHRIA 53 0.0014
310 IMPAIRED DRIVING ABILITY 16 0.0014
311 ELECTROCARDIOGRAM ABNORMAL 11 0.0014
312 GALACTORRHOEA 9 0.0014
313 HYPERTONIA 8 0.0014
314 VISUAL DISTURBANCE 8 0.0014
315 CARDIAC MURMUR 12 0.0014
316 RESPIRATORY TRACT INFECTION 36 0.0014
317 SURGERY 81 0.0014
318 MULTIPLE SCLEROSIS 66 0.0014
319 PRODUCT SUBSTITUTION ISSUE 79 0.0014
320 GASTROOESOPHAGEAL REFLUX DISEASE 110 0.0014
321 HUNGER 19 0.0014
322 TREATMENT FAILURE 113 0.0014
323 APHONIA 19 0.0014
324 TOOTH FRACTURE 15 0.0014
325 SUPRAVENTRICULAR TACHYCARDIA 13 0.0014
326 TENDONITIS 21 0.0014
327 CYSTITIS 43 0.0013
328 HYPERCHOLESTEROLAEMIA 13 0.0013
329 INJECTION SITE URTICARIA 33 0.0013
330 DIZZINESS POSTURAL 13 0.0013
331 PARTIAL SEIZURES 7 0.0013
332 ASTHMA 151 0.0013
333 UPPER-AIRWAY COUGH SYNDROME 11 0.0013
334 OPTIC NEURITIS 12 0.0013
335 NYSTAGMUS 7 0.0013
336 HYPOTHYROIDISM 42 0.0013
337 EYE MOVEMENT DISORDER 9 0.0013
338 MICTURITION URGENCY 15 0.0013
339 ACTIVITIES OF DAILY LIVING IMPAIRED 26 0.0013
340 INSURANCE ISSUE 20 0.0013
341 ONYCHOCLASIS 9 0.0013
342 GINGIVITIS 7 0.0013
343 FORMICATION 9 0.0013
344 ORAL CANDIDIASIS 17 0.0013
345 VASCULITIS 15 0.0013
346 BLOOD CHOLESTEROL INCREASED 60 0.0013
347 FLANK PAIN 12 0.0013
348 UPPER RESPIRATORY TRACT INFECTION 59 0.0013
349 GASTROENTERITIS VIRAL 23 0.0013
350 HAND FRACTURE 9 0.0013
351 INSOMNIA 337 0.0013
352 HYPOAESTHESIA 188 0.0013
353 HYPERSOMNIA 36 0.0013
354 OBESITY 20 0.0013
355 ANAPHYLACTIC REACTION 69 0.0012
356 PARAESTHESIA ORAL 18 0.0012
357 OBSESSIVE-COMPULSIVE DISORDER 10 0.0012
358 PETECHIAE 13 0.0012
359 NIGHT SWEATS 40 0.0012
360 HEMIPARESIS 21 0.0012
361 SYSTEMIC LUPUS ERYTHEMATOSUS 44 0.0012
362 COLECTOMY 7 0.0012
363 RHINORRHOEA 80 0.0012
364 PRODUCT ADMINISTRATION ERROR 25 0.0012
365 UTERINE LEIOMYOMA 9 0.0012
366 BLOOD PRESSURE SYSTOLIC INCREASED 24 0.0012
367 POST PROCEDURAL INFECTION 10 0.0012
368 ABDOMINAL PAIN 285 0.0012
369 FEELING ABNORMAL 292 0.0012
370 URINARY INCONTINENCE 36 0.0012
371 IMMUNE SYSTEM DISORDER 16 0.0012
372 CARPAL TUNNEL SYNDROME 17 0.0012
373 RHEUMATOID FACTOR POSITIVE 7 0.0012
374 EMBEDDED DEVICE 12 0.0012
375 LIVER FUNCTION TEST INCREASED 26 0.0012
376 CRYING 44 0.0012
377 IMMUNODEFICIENCY 18 0.0012
378 DRUG INEFFECTIVE 1591 0.0012
379 SOMNOLENCE 242 0.0012
380 PAIN IN JAW 34 0.0012
381 INCREASED TENDENCY TO BRUISE 11 0.0012
382 HYPOAESTHESIA ORAL 18 0.0012
383 JOINT RANGE OF MOTION DECREASED 16 0.0012
384 ECONOMIC PROBLEM 18 0.0012
385 DECREASED INTEREST 7 0.0012
386 MEMORY IMPAIRMENT 163 0.0012
387 OSTEOPENIA 18 0.0012
388 GLUCOSE TOLERANCE IMPAIRED 7 0.0012
389 GASTROINTESTINAL PAIN 13 0.0012
390 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 84 0.0012
391 CHOKING 23 0.0012
392 ORAL HERPES 23 0.0012
393 MOOD ALTERED 32 0.0012
394 THERAPEUTIC RESPONSE DECREASED 71 0.0012
395 JOINT INJURY 25 0.0012
396 INITIAL INSOMNIA 12 0.0012
397 BACK DISORDER 19 0.0012
398 AMNESIA 76 0.0012
399 ECCHYMOSIS 8 0.0012
400 SPEECH DISORDER 61 0.0012
401 SPINAL DISORDER 11 0.0012
402 PSYCHOLOGICAL TRAUMA 10 0.0012
403 PLATELET COUNT ABNORMAL 7 0.0012
404 MUSCLE STRAIN 10 0.0012
405 BURSITIS 14 0.0012
406 END STAGE RENAL DISEASE 21 0.0012
407 EYE INFECTION 13 0.0012
408 FLUSHING 117 0.0011
409 BRAIN FOG 18 0.0011
410 DRUG EFFECT LESS THAN EXPECTED 17 0.0011
411 DERMATITIS CONTACT 13 0.0011
412 DRUG ABUSER 7 0.0011
413 HEAD INJURY 36 0.0011
414 GRIP STRENGTH DECREASED 10 0.0011
415 JOINT DISLOCATION 12 0.0011
416 CONCOMITANT DISEASE AGGRAVATED 7 0.0011
417 IMMUNOSUPPRESSION 10 0.0011
418 BLOOD POTASSIUM DECREASED 34 0.0011
419 PHARYNGITIS 14 0.0011
420 EXPOSURE DURING PREGNANCY 70 0.0011
421 HAIR TEXTURE ABNORMAL 15 0.0011
422 KIDNEY INFECTION 22 0.0011
423 PALPITATIONS 131 0.0011
424 OFF LABEL USE 978 0.0011
425 ANGINA PECTORIS 32 0.0011
426 ANAL INCONTINENCE 10 0.0011
427 TONGUE DISORDER 8 0.0011
428 THERAPEUTIC RESPONSE CHANGED 7 0.0011
429 RESPIRATORY DISORDER 33 0.0011
430 INFLUENZA 123 0.0011
431 LIMB DISCOMFORT 34 0.0011
432 HYPERAESTHESIA 9 0.0011
433 ANGER 37 0.0011
434 COGNITIVE DISORDER 51 0.0011
435 THROAT IRRITATION 49 0.0011
436 CHOLECYSTITIS 13 0.0011
437 GLAUCOMA 21 0.0011
438 ACCIDENT 13 0.0011
439 MENSTRUAL DISORDER 9 0.0011
440 ACUTE CORONARY SYNDROME 9 0.0011
441 NERVE COMPRESSION 10 0.0011
442 HYPOPHOSPHATAEMIA 8 0.0011
443 INCOHERENT 7 0.0011
444 CEREBRAL DISORDER 8 0.0011
445 EOSINOPHIL COUNT INCREASED 9 0.0011
446 OBSTRUCTIVE AIRWAYS DISORDER 12 0.0011
447 ADRENAL INSUFFICIENCY 13 0.0011
448 RIB FRACTURE 22 0.0011
449 CHRONIC KIDNEY DISEASE 81 0.0011
450 BEDRIDDEN 14 0.0011
451 TOOTH INFECTION 14 0.0011
452 LOSS OF CONSCIOUSNESS 136 0.0011
453 BLOOD SODIUM DECREASED 20 0.0011
454 DRUG EXPOSURE DURING PREGNANCY 36 0.0011
455 MUSCLE SPASTICITY 13 0.0011
456 SPINAL OPERATION 13 0.0011
457 PRODUCT PACKAGING ISSUE 10 0.0011
458 MUSCULOSKELETAL DISCOMFORT 18 0.0010
459 CHEST PAIN 193 0.0010
460 PHARYNGEAL OEDEMA 16 0.0010
461 HOT FLUSH 78 0.0010
462 ANKLE FRACTURE 16 0.0010
463 MOVEMENT DISORDER 33 0.0010
464 THERAPEUTIC PRODUCT EFFECT DECREASED 46 0.0010
465 AUTOIMMUNE DISORDER 10 0.0010
466 CONTRAINDICATED PRODUCT ADMINISTERED 31 0.0010
467 COLD SWEAT 18 0.0010
468 NASAL CONGESTION 60 0.0010
469 MUSCULAR WEAKNESS 116 0.0010
470 INFLUENZA LIKE ILLNESS 84 0.0010
471 MULTIPLE ALLERGIES 8 0.0010
472 FUNGAL INFECTION 34 0.0010
473 VOMITING 479 0.0010
474 MENORRHAGIA 20 0.0010
475 TREMOR 169 0.0010
476 AFFECTIVE DISORDER 8 0.0010
477 MIDDLE INSOMNIA 19 0.0010
478 LYMPHADENOPATHY 36 0.0010
479 MUSCLE SPASMS 186 0.0010
480 DRUG SCREEN POSITIVE 8 0.0010
481 LARGE INTESTINE POLYP 7 0.0010
482 INFUSION SITE PAIN 13 0.0010
483 RESPIRATORY TRACT CONGESTION 16 0.0010
484 MYOCLONUS 12 0.0010
485 GINGIVAL PAIN 8 0.0010
486 HIATUS HERNIA 13 0.0010
487 UPPER LIMB FRACTURE 20 0.0010
488 PAIN 615 0.0010
489 BLOOD PRESSURE FLUCTUATION 24 0.0010
490 WEIGHT DECREASED 279 0.0010
491 SENSORY DISTURBANCE 16 0.0010
492 ABDOMINAL PAIN UPPER 204 0.0010
493 NERVE INJURY 11 0.0010
494 COUGH 277 0.0010
495 VISION BLURRED 135 0.0010
496 SUBARACHNOID HAEMORRHAGE 10 0.0010
497 MOTOR DYSFUNCTION 10 0.0010
498 ALANINE AMINOTRANSFERASE INCREASED 60 0.0010
499 THYROID DISORDER 15 0.0010
500 BALANCE DISORDER 84 0.0010
501 HAIR DISORDER 8 0.0010
502 DRUG INTERACTION 154 0.0010
503 MUSCULOSKELETAL CHEST PAIN 15 0.0010
504 NEUROPATHY PERIPHERAL 92 0.0010
505 CYST 12 0.0010
506 FEAR 26 0.0010
507 UNEVALUABLE EVENT 73 0.0010
508 HAIR COLOUR CHANGES 12 0.0010
509 DRUG EFFECT INCOMPLETE 35 0.0010
510 PHARMACEUTICAL PRODUCT COMPLAINT 25 0.0010
511 BASAL CELL CARCINOMA 15 0.0010
512 POLLAKIURIA 40 0.0010
513 HYPERTENSION 203 0.0010
514 DYSPNOEA EXERTIONAL 36 0.0010
515 CONTUSION 92 0.0010
516 CONSTIPATION 208 0.0010
517 THIRST 17 0.0010
518 INFUSION RELATED REACTION 63 0.0009
519 SENSATION OF FOREIGN BODY 8 0.0009
520 MENTAL IMPAIRMENT 23 0.0009
521 ARTHROPOD BITE 7 0.0009
522 TOOTH DISORDER 21 0.0009
523 CONVULSION 54 0.0009
524 ABNORMAL DREAMS 26 0.0009
525 DRY EYE 47 0.0009
526 EMOTIONAL DISORDER 29 0.0009
527 FACIAL PARALYSIS 8 0.0009
528 METRORRHAGIA 16 0.0009
529 URINARY TRACT INFECTION 160 0.0009
530 ORAL PAIN 21 0.0009
531 COORDINATION ABNORMAL 13 0.0009
532 INFLAMMATION 48 0.0009
533 POOR QUALITY SLEEP 20 0.0009
534 ARTHRITIS 73 0.0009
535 INJECTION SITE BRUISING 74 0.0009
536 BURNING SENSATION 65 0.0009
537 BLINDNESS UNILATERAL 13 0.0009
538 INFLAMMATORY BOWEL DISEASE 9 0.0009
539 HEPATOMEGALY 9 0.0009
540 GROIN PAIN 8 0.0009
541 BACK PAIN 211 0.0009
542 CHILLS 106 0.0009
543 PSYCHOMOTOR HYPERACTIVITY 15 0.0009
544 ASPARTATE AMINOTRANSFERASE INCREASED 48 0.0009
545 EXPIRED PRODUCT ADMINISTERED 30 0.0009
546 DIVERTICULITIS 25 0.0009
547 MUSCULOSKELETAL STIFFNESS 79 0.0009
548 CEREBRAL INFARCTION 22 0.0009
549 DRY MOUTH 73 0.0009
550 BLOOD PRESSURE INCREASED 137 0.0009
551 QUALITY OF LIFE DECREASED 12 0.0009
552 SMALL INTESTINAL OBSTRUCTION 11 0.0009
553 VAGINAL DISCHARGE 9 0.0009
554 FALL 296 0.0009
555 PSORIATIC ARTHROPATHY 36 0.0009
556 DRY THROAT 9 0.0009
557 PRESCRIBED OVERDOSE 17 0.0009
558 SLEEP DISORDER 62 0.0009
559 DIZZINESS 438 0.0009
560 HEART RATE INCREASED 87 0.0009
561 DYSGEUSIA 65 0.0009
562 PRODUCT DOSE OMISSION 57 0.0009
563 HAEMORRHOIDS 17 0.0009
564 HERPES ZOSTER 50 0.0009
565 POOR VENOUS ACCESS 9 0.0009
566 TACHYCARDIA 77 0.0009
567 VENTRICULAR EXTRASYSTOLES 9 0.0009
568 MUSCLE DISORDER 7 0.0009
569 OROPHARYNGEAL PAIN 80 0.0009
570 MATERNAL EXPOSURE DURING PREGNANCY 77 0.0009
571 DISABILITY 17 0.0009
572 THINKING ABNORMAL 16 0.0009
573 BACTERIAL INFECTION 16 0.0009
574 NASOPHARYNGITIS 158 0.0009
575 DEFORMITY 8 0.0009
576 FATIGUE 666 0.0009
577 MULTIPLE FRACTURES 14 0.0009
578 ARTHRALGIA 354 0.0009
579 MENTAL DISORDER 37 0.0008
580 CONFUSIONAL STATE 137 0.0008
581 SNEEZING 19 0.0008
582 GASTRIC DISORDER 29 0.0008
583 VIRAL INFECTION 28 0.0008
584 SKIN DISORDER 28 0.0008
585 JOINT STIFFNESS 22 0.0008
586 PAIN IN EXTREMITY 247 0.0008
587 GAIT INABILITY 28 0.0008
588 WRIST FRACTURE 10 0.0008
589 DYSMENORRHOEA 11 0.0008
590 ADVERSE REACTION 11 0.0008
591 ERUCTATION 16 0.0008
592 INJECTION SITE WARMTH 17 0.0008
593 EMOTIONAL DISTRESS 100 0.0008
594 WRONG TECHNIQUE IN DRUG USAGE PROCESS 30 0.0008
595 INADEQUATE ANALGESIA 7 0.0008
596 ABORTION SPONTANEOUS 33 0.0008
597 MYALGIA 140 0.0008
598 SCIATICA 13 0.0008
599 ACUTE MYOCARDIAL INFARCTION 24 0.0008
600 RED BLOOD CELL SEDIMENTATION RATE INCREASED 9 0.0008
601 FOOT DEFORMITY 9 0.0008
602 URTICARIA 136 0.0008
603 ABNORMAL BEHAVIOUR 32 0.0008
604 KNEE ARTHROPLASTY 17 0.0008
605 GINGIVAL BLEEDING 11 0.0008
606 MALNUTRITION 9 0.0008
607 TOOTH EXTRACTION 10 0.0008
608 EATING DISORDER 17 0.0008
609 SEIZURE 92 0.0008
610 MITRAL VALVE INCOMPETENCE 9 0.0008
611 WEIGHT INCREASED 178 0.0008
612 PROCEDURAL PAIN 22 0.0008
613 LIVER FUNCTION TEST ABNORMAL 23 0.0008
614 MUSCLE ATROPHY 10 0.0008
615 MUSCULOSKELETAL DISORDER 15 0.0008
616 DEHYDRATION 105 0.0008
617 MASS 11 0.0008
618 RHEUMATOID ARTHRITIS 89 0.0008
619 POST PROCEDURAL COMPLICATION 15 0.0008
620 MYOSITIS 7 0.0008
621 INTENTIONAL PRODUCT USE ISSUE 68 0.0008
622 OROPHARYNGEAL DISCOMFORT 7 0.0008
623 NERVOUS SYSTEM DISORDER 24 0.0008
624 NERVOUSNESS 40 0.0008
625 VAGINAL HAEMORRHAGE 33 0.0008
626 DYSPNOEA 430 0.0008
627 ANKYLOSING SPONDYLITIS 10 0.0008
628 RASH PAPULAR 17 0.0008
629 GRAND MAL CONVULSION 7 0.0008
630 FEELING COLD 21 0.0008
631 MOOD SWINGS 24 0.0008
632 MALAISE 329 0.0007
633 APPENDICITIS 7 0.0007
634 PREGNANCY 15 0.0007
635 AGITATION 55 0.0007
636 LIVER DISORDER 33 0.0007
637 WHEEZING 44 0.0007
638 DECREASED ACTIVITY 8 0.0007
639 FEEDING DISORDER 15 0.0007
640 SKIN LACERATION 8 0.0007
641 PULMONARY THROMBOSIS 8 0.0007
642 DISORIENTATION 29 0.0007
643 IMPAIRED HEALING 24 0.0007
644 INJECTION SITE SWELLING 56 0.0007
645 LETHARGY 42 0.0007
646 ISCHAEMIC STROKE 13 0.0007
647 AFFECT LABILITY 7 0.0007
648 BLOOD ALKALINE PHOSPHATASE INCREASED 18 0.0007
649 DRUG ABUSE 60 0.0007
650 INJECTION SITE DISCOLOURATION 9 0.0007
651 SKIN DISCOLOURATION 33 0.0007
652 TOOTHACHE 13 0.0007
653 OSTEOMYELITIS 13 0.0007
654 ABDOMINAL DISCOMFORT 120 0.0007
655 PERICARDITIS 12 0.0007
656 COELIAC DISEASE 7 0.0007
657 TYPE 2 DIABETES MELLITUS 24 0.0007
658 TRANSIENT ISCHAEMIC ATTACK 24 0.0007
659 BREAST CANCER FEMALE 19 0.0007
660 GAIT DISTURBANCE 136 0.0007
661 REBOUND EFFECT 8 0.0007
662 DEPRESSED LEVEL OF CONSCIOUSNESS 28 0.0007
663 INJECTION SITE IRRITATION 9 0.0007
664 MUSCULOSKELETAL PAIN 37 0.0007
665 ARTHROPATHY 39 0.0007
666 DIARRHOEA 452 0.0007
667 SYNCOPE 70 0.0007
668 INJECTION SITE REACTION 48 0.0007
669 SKIN ULCER 18 0.0007
670 IMPAIRED QUALITY OF LIFE 10 0.0007
671 DYSPHAGIA 66 0.0007
672 LACRIMATION INCREASED 21 0.0007
673 CELLULITIS 35 0.0007
674 SKIN LESION 19 0.0007
675 ULCER 11 0.0007
676 HEPATIC ENZYME INCREASED 47 0.0007
677 MADAROSIS 8 0.0007
678 DYSSTASIA 20 0.0007
679 RESTLESSNESS 25 0.0007
680 PULMONARY CONGESTION 9 0.0007
681 SARS-COV-2 TEST POSITIVE 9 0.0007
682 APPLICATION SITE PAIN 15 0.0007
683 INCREASED APPETITE 13 0.0007
684 ILLNESS 70 0.0007
685 LOWER LIMB FRACTURE 13 0.0007
686 FOETAL EXPOSURE DURING PREGNANCY 55 0.0007
687 ABDOMINAL PAIN LOWER 17 0.0007
688 INJECTION SITE PAIN 206 0.0007
689 THROMBOSIS 54 0.0007
690 DYSTONIA 13 0.0007
691 PRODUCT DOSE OMISSION ISSUE 197 0.0007
692 MUSCLE RIGIDITY 8 0.0007
693 ALOPECIA 131 0.0007
694 STAPHYLOCOCCAL INFECTION 22 0.0007
695 SYNOVITIS 12 0.0007
696 SKIN FISSURES 13 0.0007
697 MOUTH ULCERATION 14 0.0007
698 INJECTION SITE HAEMORRHAGE 53 0.0007
699 VISUAL IMPAIRMENT 82 0.0007
700 PALLOR 18 0.0007
701 INJECTION SITE PRURITUS 44 0.0007
702 DEVICE FAILURE 10 0.0007
703 OEDEMA PERIPHERAL 80 0.0007
704 EYE PAIN 37 0.0007
705 IMPAIRED WORK ABILITY 14 0.0007
706 MOBILITY DECREASED 47 0.0007
707 HEREDITARY ANGIOEDEMA 7 0.0007
708 PRESCRIBED UNDERDOSE 13 0.0007
709 WHITE BLOOD CELL COUNT INCREASED 25 0.0007
710 CANDIDA INFECTION 11 0.0007
711 PRODUCTIVE COUGH 31 0.0006
712 BONE PAIN 38 0.0006
713 CONDITION AGGRAVATED 197 0.0006
714 ABASIA 16 0.0006
715 CONJUNCTIVITIS 12 0.0006
716 ASTHENIA 242 0.0006
717 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 11 0.0006
718 CLOSTRIDIUM DIFFICILE INFECTION 14 0.0006
719 GASTROINTESTINAL DISORDER 57 0.0006
720 SINUS TACHYCARDIA 9 0.0006
721 IRRITABILITY 38 0.0006
722 GASTRIC ULCER 12 0.0006
723 LOCAL SWELLING 11 0.0006
724 SWELLING 59 0.0006
725 HYPERTENSIVE CRISIS 7 0.0006
726 COVID-19 110 0.0006
727 OEDEMA 34 0.0006
728 DEVICE DEPLOYMENT ISSUE 8 0.0006
729 DEPRESSED MOOD 33 0.0006
730 ABDOMINAL DISTENSION 65 0.0006
731 BLOOD CALCIUM DECREASED 7 0.0006
732 ANOSMIA 9 0.0006
733 HYPERTHYROIDISM 9 0.0006
734 PYREXIA 215 0.0006
735 CHROMATURIA 14 0.0006
736 AGGRESSION 31 0.0006
737 PRODUCT USE ISSUE 116 0.0006
738 APATHY 9 0.0006
739 GASTROENTERITIS 9 0.0006
740 MENTAL STATUS CHANGES 17 0.0006
741 RASH PRURITIC 33 0.0006
742 CEREBROVASCULAR ACCIDENT 103 0.0006
743 BLISTER 34 0.0006
744 RECTAL HAEMORRHAGE 26 0.0006
745 DRUG DOSE OMISSION 100 0.0006
746 PULMONARY MASS 9 0.0006
747 COLON CANCER 9 0.0006
748 BONE DISORDER 11 0.0006
749 ELECTROLYTE IMBALANCE 7 0.0006
750 EPISTAXIS 45 0.0006
751 LIP SWELLING 20 0.0006
752 PERIPHERAL SWELLING 92 0.0006
753 WITHDRAWAL SYNDROME 25 0.0006
754 INJECTION SITE MASS 22 0.0006
755 RED BLOOD CELL COUNT DECREASED 17 0.0006
756 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 31 0.0006
757 BLOOD COUNT ABNORMAL 9 0.0006
758 TASTE DISORDER 12 0.0006
759 EYE SWELLING 22 0.0006
760 HEPATITIS 15 0.0006
761 DEVICE RELATED INFECTION 9 0.0006
762 PERIPHERAL COLDNESS 8 0.0006
763 GLOSSODYNIA 13 0.0006
764 JOINT SWELLING 70 0.0006
765 LOCALISED INFECTION 14 0.0006
766 EYE DISORDER 19 0.0006
767 NOCTURIA 7 0.0006
768 PRODUCT QUALITY ISSUE 78 0.0006
769 INTENTIONAL DRUG MISUSE 12 0.0006
770 DEAFNESS 15 0.0006
771 INFECTION 83 0.0006
772 INJECTION SITE ERYTHEMA 71 0.0006
773 PRURITUS 218 0.0006
774 TARDIVE DYSKINESIA 16 0.0006
775 HALLUCINATION, AUDITORY 9 0.0006
776 DYSKINESIA 23 0.0006
777 PNEUMONIA 183 0.0006
778 BLINDNESS 23 0.0006
779 HYPOKALAEMIA 26 0.0006
780 BRONCHOSPASM 8 0.0006
781 RENAL FAILURE 74 0.0006
782 INTESTINAL OBSTRUCTION 21 0.0006
783 ELECTROCARDIOGRAM QT PROLONGED 20 0.0006
784 HAEMATOCRIT DECREASED 11 0.0006
785 COMPLICATION OF DEVICE REMOVAL 10 0.0006
786 PULMONARY ARTERIAL HYPERTENSION 8 0.0006
787 ARRHYTHMIA 26 0.0005
788 INTENTIONAL PRODUCT MISUSE 48 0.0005
789 MANIA 9 0.0005
790 MYDRIASIS 7 0.0005
791 SUICIDE ATTEMPT 33 0.0005
792 VISUAL ACUITY REDUCED 18 0.0005
793 BLOOD PRESSURE DECREASED 36 0.0005
794 DISCOMFORT 33 0.0005
795 SKIN HAEMORRHAGE 8 0.0005
796 BODY TEMPERATURE INCREASED 11 0.0005
797 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 109 0.0005
798 DIABETES MELLITUS 41 0.0005
799 CATARACT 32 0.0005
800 COLITIS ULCERATIVE 24 0.0005
801 NODULE 7 0.0005
802 APPLICATION SITE ERYTHEMA 14 0.0005
803 ADVERSE EVENT 49 0.0005
804 PREMATURE BABY 16 0.0005
805 ANAEMIA 101 0.0005
806 DEVICE DIFFICULT TO USE 35 0.0005
807 PULMONARY HYPERTENSION 11 0.0005
808 ILL-DEFINED DISORDER 32 0.0005
809 INTENTIONAL DOSE OMISSION 15 0.0005
810 ACUTE RESPIRATORY FAILURE 10 0.0005
811 NO ADVERSE EVENT 94 0.0005
812 BLOOD BILIRUBIN INCREASED 14 0.0005
813 ORTHOSTATIC HYPOTENSION 9 0.0005
814 DECREASED APPETITE 120 0.0005
815 FEMUR FRACTURE 16 0.0005
816 NEEDLE ISSUE 15 0.0005
817 ADVERSE DRUG REACTION 46 0.0005
818 STOMATITIS 31 0.0005
819 PANCREATITIS 27 0.0005
820 BLOOD TRIGLYCERIDES INCREASED 9 0.0005
821 CYANOSIS 8 0.0005
822 DRUG ERUPTION 9 0.0005
823 ANAPHYLACTIC SHOCK 13 0.0005
824 UNRESPONSIVE TO STIMULI 13 0.0005
825 BLOOD PRESSURE ABNORMAL 10 0.0005
826 HYPOMAGNESAEMIA 7 0.0005
827 DRUG WITHDRAWAL SYNDROME 44 0.0005
828 BLOOD TEST ABNORMAL 7 0.0005
829 INCORRECT DOSE ADMINISTERED BY DEVICE 13 0.0005
830 PRESYNCOPE 12 0.0005
831 INJURY ASSOCIATED WITH DEVICE 10 0.0005
832 DYSURIA 18 0.0005
833 MEDICATION ERROR 27 0.0005
834 OCULAR HYPERAEMIA 23 0.0005
835 VENTRICULAR TACHYCARDIA 8 0.0005
836 COMPLICATION ASSOCIATED WITH DEVICE 7 0.0005
837 URINARY RETENTION 16 0.0005
838 UNDERDOSE 35 0.0005
839 DERMATITIS 10 0.0005
840 MYOCARDIAL INFARCTION 83 0.0005
841 GENERAL PHYSICAL HEALTH DETERIORATION 55 0.0005
842 PSYCHOTIC DISORDER 14 0.0005
843 FLUID RETENTION 24 0.0005
844 WHITE BLOOD CELL COUNT DECREASED 51 0.0005
845 RASH 205 0.0005
846 CIRCULATORY COLLAPSE 8 0.0005
847 HERNIA 9 0.0005
848 HYPOACUSIS 20 0.0005
849 INCORRECT PRODUCT ADMINISTRATION DURATION 10 0.0005
850 ALTERED STATE OF CONSCIOUSNESS 10 0.0005
851 INJECTION SITE RASH 14 0.0005
852 AMENORRHOEA 8 0.0005
853 DELUSION 7 0.0005
854 SPINAL FRACTURE 9 0.0004
855 COLITIS 17 0.0004
856 THERAPY CESSATION 23 0.0004
857 MENSTRUATION IRREGULAR 12 0.0004
858 DRUG EFFECT DECREASED 24 0.0004
859 PNEUMOTHORAX 7 0.0004
860 ABSCESS 7 0.0004
861 DEVICE DISLOCATION 19 0.0004
862 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 31 0.0004
863 DEVICE ISSUE 39 0.0004
864 HAEMATEMESIS 11 0.0004
865 BLOOD GLUCOSE ABNORMAL 8 0.0004
866 WOUND 12 0.0004
867 RASH MACULAR 15 0.0004
868 ERYTHEMA 88 0.0004
869 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 77 0.0004
870 HEART RATE DECREASED 15 0.0004
871 TUBULOINTERSTITIAL NEPHRITIS 8 0.0004
872 HALLUCINATION, VISUAL 9 0.0004
873 HALLUCINATION 32 0.0004
874 PRODUCT DOSE OMISSION IN ERROR 12 0.0004
875 DRUG ADMINISTRATION ERROR 13 0.0004
876 THERAPY NON-RESPONDER 19 0.0004
877 ACNE 32 0.0004
878 PRODUCT PRESCRIBING ERROR 10 0.0004
879 LOWER RESPIRATORY TRACT INFECTION 19 0.0004
880 PRURITUS GENERALISED 9 0.0004
881 LUNG DISORDER 20 0.0004
882 PARANOIA 7 0.0004
883 FLATULENCE 23 0.0004
884 HIP FRACTURE 13 0.0004
885 COMPLICATION OF DEVICE INSERTION 8 0.0004
886 INCORRECT DOSE ADMINISTERED 91 0.0004
887 HEART RATE IRREGULAR 9 0.0004
888 APPLICATION SITE PRURITUS 9 0.0004
889 CORONARY ARTERY DISEASE 12 0.0004
890 HYPOTENSION 79 0.0004
891 EPILEPSY 12 0.0004
892 HYPOPHAGIA 10 0.0004
893 INCORRECT DRUG ADMINISTRATION DURATION 11 0.0004
894 CEREBRAL HAEMORRHAGE 14 0.0004
895 GOUT 7 0.0004
896 LEUKOCYTOSIS 7 0.0004
897 HAEMATOMA 10 0.0004
898 TOOTH LOSS 8 0.0004
899 CARDIAC ARREST 31 0.0004
900 LABORATORY TEST ABNORMAL 11 0.0004
901 PAIN OF SKIN 10 0.0004
902 DEVICE MALFUNCTION 26 0.0004
903 FRACTURE 7 0.0004
904 HYPOXIA 13 0.0004
905 PROTEINURIA 7 0.0004
906 PRODUCT DISPENSING ERROR 8 0.0004
907 TREATMENT NONCOMPLIANCE 20 0.0004
908 DRUG PRESCRIBING ERROR 7 0.0004
909 HAEMATOCHEZIA 20 0.0004
910 RESPIRATORY DISTRESS 10 0.0004
911 AGEUSIA 9 0.0004
912 PSORIASIS 47 0.0004
913 ACCIDENTAL EXPOSURE TO PRODUCT 37 0.0004
914 PANCREATITIS ACUTE 8 0.0004
915 DRUG-INDUCED LIVER INJURY 11 0.0004
916 RASH GENERALISED 9 0.0003
917 EYE IRRITATION 20 0.0003
918 INTENTIONAL SELF-INJURY 7 0.0003
919 BLOOD GLUCOSE DECREASED 16 0.0003
920 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 16 0.0003
921 ACUTE KIDNEY INJURY 50 0.0003
922 RESPIRATORY ARREST 9 0.0003
923 ENCEPHALOPATHY 8 0.0003
924 HAEMOGLOBIN DECREASED 33 0.0003
925 OXYGEN SATURATION DECREASED 18 0.0003
926 HYPONATRAEMIA 18 0.0003
927 GLYCOSYLATED HAEMOGLOBIN INCREASED 8 0.0003
928 TRANSAMINASES INCREASED 7 0.0003
929 SKIN EXFOLIATION 26 0.0003
930 PRODUCT ADHESION ISSUE 11 0.0003
931 RENAL FAILURE ACUTE 13 0.0003
932 RENAL INJURY 9 0.0003
933 HOSPITALISATION 46 0.0003
934 CARDIAC DISORDER 28 0.0003
935 JAUNDICE 8 0.0003
936 HAEMORRHAGE 31 0.0003
937 INTENTIONAL OVERDOSE 19 0.0003
938 DELIRIUM 10 0.0003
939 NEOPLASM PROGRESSION 10 0.0003
940 OVERDOSE 61 0.0003
941 PNEUMONIA ASPIRATION 7 0.0003
942 COMPLETED SUICIDE 23 0.0003
943 BLOOD CREATININE INCREASED 18 0.0003
944 ACCIDENTAL OVERDOSE 10 0.0003
945 RASH ERYTHEMATOUS 13 0.0003
946 EXTRA DOSE ADMINISTERED 11 0.0003
947 DEVICE BREAKAGE 11 0.0003
948 ECZEMA 14 0.0003
949 RENAL DISORDER 12 0.0003
950 BONE DENSITY DECREASED 8 0.0003
951 THERAPY INTERRUPTED 18 0.0003
952 SEPSIS 28 0.0003
953 DEMENTIA 7 0.0003
954 DRY SKIN 33 0.0002
955 BLOOD GLUCOSE INCREASED 46 0.0002
956 BLOOD CREATINE PHOSPHOKINASE INCREASED 7 0.0002
957 DRUG DOSE OMISSION BY DEVICE 19 0.0002
958 LEUKOPENIA 12 0.0002
959 ASCITES 7 0.0002
960 EYE PRURITUS 8 0.0002
961 RENAL IMPAIRMENT 20 0.0002
962 ATRIAL FIBRILLATION 23 0.0002
963 RESPIRATORY FAILURE 17 0.0002
964 DEVICE EXPULSION 15 0.0002
965 BREAST CANCER 21 0.0002
966 NEUTROPHIL COUNT DECREASED 9 0.0002
967 C-REACTIVE PROTEIN INCREASED 8 0.0002
968 METABOLIC ACIDOSIS 7 0.0002
969 SKIN IRRITATION 10 0.0002
970 PLATELET COUNT DECREASED 23 0.0002
971 GASTROINTESTINAL HAEMORRHAGE 18 0.0002
972 HEPATIC FUNCTION ABNORMAL 8 0.0002
973 DERMATITIS ATOPIC 11 0.0002
974 BRADYCARDIA 11 0.0002
975 DRUG DEPENDENCE 33 0.0002
976 HYPERKALAEMIA 7 0.0002
977 INCORRECT ROUTE OF DRUG ADMINISTRATION 7 0.0002
978 PRODUCT STORAGE ERROR 17 0.0002
979 CARDIO-RESPIRATORY ARREST 8 0.0002
980 NEUTROPENIA 26 0.0002
981 PANCYTOPENIA 10 0.0002
982 PLEURAL EFFUSION 10 0.0002
983 CARDIAC FAILURE CONGESTIVE 11 0.0001
984 THROMBOCYTOPENIA 15 0.0001
985 DEPENDENCE 7 0.0001
986 DISEASE PROGRESSION 15 0.0001
987 SKIN BURNING SENSATION 9 0.0001
988 CARDIAC FAILURE 9 0.0001
989 NEOPLASM MALIGNANT 7 0.0001
990 TOXICITY TO VARIOUS AGENTS 14 0.0001
991 DEATH 68 0.0001